ICCA in June launch of LRI research drive

13 April 1999 18:23  [Source: ICIS news]

LONDON (CNI)--International chemical associations are planning to formally launch their $30m (Euro27.8m) a year long-range research initiative (LRI) into environmental and human health issues at the World Health Organisation (WHO) conference on 16 June, CNI was told Tuesday.

LRI has a research hot-list of nine items in a series of rolling three-year programmes. The joint initiative, developed through the International Council of Chemical Associations (ICCA), is mostly being funded by the US Chemical Manufacturers Association (CMA). Its partners in the research drive are the European Chemical Industry Council (Cefic) and the Japanese Chemical Industry Association (JCIA).

Under the LRI banner, the chemical industry bodies aim to push their communication of research efforts and results to scientific, business and the general public to show what has been found through its different investigations, such as their international collaborative endocrine disruptors studies. Further research on the hot list are: exposure assessment, risk assessment, carcinogenesis, ecosystem dynamics, neurotoxicity, respiratory toxicity and immunotoxicity.

Initial planning for LRI began in 1997 and Cefic formally started work on the programme in January, it said. The LRI supporters plan to launch the initiative at the WHO conference because it is expected that environment ministers from a number of countries will adopt a declaration on environmental and human research issues at the event. The declaration has been drawn up by the European Science Foundation (ESF) in collaboration with WHO and the European Commission (EC).

By: Patrick Reynolds
+44 208 652 3214

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly